Tandem Diabetes Care, Inc.
TNDM
$21.90
$0.311.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 290.38M | 249.25M | 240.68M | 234.42M | 282.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 290.38M | 249.25M | 240.68M | 234.42M | 282.65M |
| Cost of Revenue | 122.92M | 114.96M | 114.82M | 116.02M | 125.19M |
| Gross Profit | 167.46M | 134.29M | 125.86M | 118.41M | 157.46M |
| SG&A Expenses | 113.10M | 106.44M | 109.60M | 104.97M | 105.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 282.09M | 269.32M | 272.54M | 268.92M | 283.23M |
| Operating Income | 8.29M | -20.06M | -31.86M | -34.49M | -582.00K |
| Income Before Tax | 4.68M | -25.14M | -57.72M | -122.09M | 16.00K |
| Income Tax Expenses | 5.27M | -3.98M | -5.32M | 8.47M | -739.00K |
| Earnings from Continuing Operations | -589.00K | -21.17M | -52.40M | -130.56M | 755.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -589.00K | -21.17M | -52.40M | -130.56M | 755.00K |
| EBIT | 8.29M | -20.06M | -31.86M | -34.49M | -582.00K |
| EBITDA | 12.79M | -15.57M | -27.49M | -30.18M | 3.66M |
| EPS Basic | -0.01 | -0.31 | -0.78 | -1.97 | 0.01 |
| Normalized Basic EPS | 0.04 | -0.21 | -0.35 | -0.34 | 0.02 |
| EPS Diluted | -0.01 | -0.31 | -0.78 | -1.97 | 0.01 |
| Normalized Diluted EPS | 0.04 | -0.21 | -0.35 | -0.34 | 0.02 |
| Average Basic Shares Outstanding | 68.01M | 67.65M | 67.05M | 66.40M | 65.94M |
| Average Diluted Shares Outstanding | 68.01M | 67.65M | 67.05M | 66.40M | 66.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |